Back

Integrative proteomics and network biology approach to identify potential urine based biomarkers for tuberculosis.

Subramaniam, S.; Varshney, A.; Singla, R.; Behera, D.; NANDA, R.

2023-05-21 infectious diseases
10.1101/2023.05.19.23289652 medRxiv
Show abstract

Urine based biomarker discovery employing proteomics platform has been successfully attempted for multiple diseases. Urine is an excellent source of biomarker discovery but its potential is not fully tapped in tuberculosis (TB) diagnostics. In the present study, proteomic profiling of urine samples from thirty five subjects (Mean age=41 years (15-76), M/F=28/7) belonging to active TB, latent TB, lung cancer, chronic obstructive pulmonary disorders (COPD) and healthy subjects were carried out employing a robust multiplex technique. We identified 131 proteins out of which 16 molecules showed at least two-fold change in TB. The study identified a signature of three putative markers, leucine-rich alpha-2-glycoprotein (up-regulated), roundabout homolog 4 and isoform 2 of prostatic acid phosphatase (down-regulated) that could differentiate active TB from other pulmonary diseases. Besides, we investigated whether a network based approach can be efficiently used to expand dynamic coverage, gain a comprehensive view of underlying perturbed functions during the infection and to discover potential biomarkers. While comparing the functionally associated sub-networks of active TB with healthy urine proteome, we identified 54 proteins from the discriminative TB sub-network, some of which are known to be involved in the infection process. Few examples in this study like serpin peptidase inhibitor and catenin that has not been identified in the experiment but detected in the difference network demonstrate that proteomic profiling when integrated with network biology method could be a holistic approach to expand the dynamic range and identify potential candidate biomarkers and also provide a broad overview of perturbed functions during the infection.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
PLOS ONE
5266 papers in training set
Top 12%
15.4%
2
Frontiers in Immunology
638 papers in training set
Top 2%
8.0%
3
Clinical Proteomics
11 papers in training set
Top 0.1%
6.9%
4
Scientific Reports
3612 papers in training set
Top 10%
6.9%
5
PROTEOMICS
43 papers in training set
Top 0.1%
5.6%
6
International Journal of Molecular Sciences
494 papers in training set
Top 2%
4.9%
7
Biology
45 papers in training set
Top 0.1%
3.6%
50% of probability mass above
8
Frontiers in Cellular and Infection Microbiology
109 papers in training set
Top 0.5%
3.5%
9
Microbiology Spectrum
469 papers in training set
Top 4%
3.3%
10
ACS Omega
105 papers in training set
Top 0.6%
3.2%
11
Heliyon
152 papers in training set
Top 3%
1.9%
12
Frontiers in Molecular Biosciences
102 papers in training set
Top 0.6%
1.8%
13
Journal of Proteomics
28 papers in training set
Top 0.3%
1.8%
14
Frontiers in Medicine
120 papers in training set
Top 2%
1.5%
15
BioMed Research International
28 papers in training set
Top 1%
1.2%
16
Molecular Omics
23 papers in training set
Top 0.2%
1.2%
17
Journal of Proteome Research
234 papers in training set
Top 1%
1.2%
18
Genomics
64 papers in training set
Top 1%
1.1%
19
BMC Infectious Diseases
133 papers in training set
Top 4%
1.0%
20
Diagnostics
50 papers in training set
Top 2%
0.9%
21
iScience
1154 papers in training set
Top 33%
0.9%
22
Biomolecules
100 papers in training set
Top 3%
0.9%
23
Journal of Translational Medicine
57 papers in training set
Top 3%
0.6%
24
Tuberculosis
11 papers in training set
Top 0.2%
0.6%
25
Vaccines
198 papers in training set
Top 4%
0.6%
26
Royal Society Open Science
214 papers in training set
Top 7%
0.6%
27
Bioscience Reports
27 papers in training set
Top 2%
0.6%
28
Viruses
332 papers in training set
Top 5%
0.6%
29
Immunology
28 papers in training set
Top 0.8%
0.6%
30
Biomedicines
67 papers in training set
Top 3%
0.6%